ID: ALA3091617

Max Phase: Preclinical

Molecular Formula: C19H15NO5

Molecular Weight: 337.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nc(Cc2cccc3ccccc23)c(C(=O)O)c(C(=O)O)c1O

Standard InChI:  InChI=1S/C19H15NO5/c1-10-17(21)16(19(24)25)15(18(22)23)14(20-10)9-12-7-4-6-11-5-2-3-8-13(11)12/h2-8,21H,9H2,1H3,(H,22,23)(H,24,25)

Standard InChI Key:  GWBXHPALJXVBSG-UHFFFAOYSA-N

Associated Targets(Human)

P2X purinoceptor 7 5534 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P2X purinoceptor 3 1991 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2X purinoceptor 1 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 337.33Molecular Weight (Monoisotopic): 337.0950AlogP: 3.24#Rotatable Bonds: 4
Polar Surface Area: 107.72Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.60CX Basic pKa: 2.05CX LogP: 3.29CX LogD: -2.24
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.67Np Likeness Score: -0.13

References

1. Cho JH, Jung KY, Jung Y, Kim MH, Ko H, Park CS, Kim YC..  (2013)  Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators.,  70  [PMID:24246730] [10.1016/j.ejmech.2013.10.026]

Source